Determination of the effect of age and gender on the norepinephrine transporter availability by using positron emission tomography with [F-18]FMeNER-D2

Determination of the effect of age and gender on the norepinephrine transporter availability by using positron emission tomography with [F-18]FMeNER-D2 - The effect of age and gender on the norepinephrine transporter availability

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007163

Enrollment

Registered

2012-01-30

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal volunteers

Interventions

Intravenous injection of [F-18]FMeNER-D2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: No current or history of psychiatric disorders and absence of severe somatic diseases. Ability to understand an explanation document and give consent.

Exclusion criteria

Exclusion criteria: Presence of severe diseases and currently undergoing treatment for them. Pregnant or possibility of pregnancy. Currently breastfeeding. Participation in the other studies involving the use of nuclear medicine within 6 months. Judged inappropriate as a subject by the investigators.

Design outcomes

Primary

Measure	Time frame
The effect of age and gender on the norepinephrine transporter availability	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026